Related references
Note: Only part of the references are listed.Does dietary fat affect advanced glycation end products and their receptors? A systematic review of clinical trials
Nelia P. Mendes et al.
NUTRITION REVIEWS (2022)
Diabetes Mellitus, Race, and Effects of Omega-3 Fatty Acids on Incidence of Heart Failure Hospitalization
Luc Djousse et al.
JACC-HEART FAILURE (2022)
Effect of Omega-3 Dosage on Cardiovascular Outcomes: An Updated Meta-Analysis and Meta-Regression of Interventional Trials
Aldo A. Bernasconi et al.
MAYO CLINIC PROCEEDINGS (2021)
Effects of n-3 Fatty Acid Supplements in Elderly Patients After Myocardial Infarction A Randomized, Controlled Trial
Are Annesonn Kalstad et al.
CIRCULATION (2021)
Effect of Long-Term Marine-3 Fatty Acids Supplementation on the Risk of Atrial Fibrillation in Randomized Controlled Trials of Cardiovascular Outcomes: A Systematic Review and Meta-Analysis
Baris Gencer et al.
CIRCULATION (2021)
Current trends in epidemiology of cardiovascular disease and cardiovascular risk management in type 2 diabetes
Jae-Seung Yun et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2021)
Cardiovascular Impact of Nutritional Supplementation With Omega-3 Fatty Acids JACC Focus Seminar
Richard L. Weinberg et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)
Effect of Marine Omega-3 Fatty Acid and Vitamin D Supplementation on Incident Atrial Fibrillation: A Randomized Clinical Trial
Christine M. Albert et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Emerging Mechanisms of Cardiovascular Protection for the Omega-3 Fatty Acid Eicosapentaenoic Acid
R. Preston Mason et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2020)
Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk The STRENGTH Randomized Clinical Trial
Stephen J. Nicholls et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Inequity in consumption of goods and services adds to racial-ethnic disparities in air pollution exposure
Christopher W. Tessum et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Marine n-3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer
JoAnn E. Manson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
Deepak L. Bhatt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Eicosapentaenoic acid inhibits oxidation of high density lipoprotein particles in a manner distinct from docosahexaenoic acid
Samuel C. R. Sherratt et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Eicosapentaenoic acid improves endothelial function and nitric oxide bioavailability in a manner that is enhanced in combination with a statin
R. Preston Mason et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Omega-3 polyunsaturated fatty acids favourably modulate cardiometabolic biomarkers in type 2 diabetes: a meta-analysis and meta-regression of randomized controlled trials
Lauren L. O'Mahoney et al.
CARDIOVASCULAR DIABETOLOGY (2018)
Omega-3 Polyunsaturated Fatty Acids and Their Health Benefits
Fereidoon Shahidi et al.
ANNUAL REVIEW OF FOOD SCIENCE AND TECHNOLOGY, VOL 9 (2018)
Effects of n-3 Fatty Acid Supplements in Diabetes Mellitus
Louise Bowman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Advanced Glycation End Products, Oxidation Products, and Incident Cardiovascular Events in Patients With Type 2 Diabetes
Juraj Koska et al.
DIABETES CARE (2018)
Precision Nutrition and Omega-3 Polyunsaturated Fatty Acids: A Case for Personalized Supplementation Approaches for the Prevention and Management of Human Diseases
Floyd H. Chilton et al.
NUTRIENTS (2017)
Combination of n-3 polyunsaturated fatty acids reduces atherogenesis in apolipoprotein E-deficient mice by inhibiting macrophage activation
Akira Takashima et al.
ATHEROSCLEROSIS (2016)
Dietary and pharmacological intervention to mitigate the cardiopulmonary effects of air pollution toxicity
Haiyan Tong
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2016)
ω-3 Polyunsaturated Fatty Acid Biomarkers and Coronary Heart Disease Pooling Project of 19 Cohort Studies
Liana C. Del Gobbo et al.
JAMA INTERNAL MEDICINE (2016)
Greenlandic Inuit show genetic signatures of diet and climate adaptation
Matteo Fumagalli et al.
SCIENCE (2015)
Omega-3 PUFAs improved endothelial function and arterial stiffness with a parallel antiinflammatory effect in adults with metabolic syndrome
Dimitris Tousoulis et al.
ATHEROSCLEROSIS (2014)
n-3 Fatty Acids in Patients with Multiple Cardiovascular Risk Factors
Maria Carla Roncaglioni et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Efficacy and Safety of Eicosapentaenoic Acid Ethyl Ester (AMR101) Therapy in Statin-Treated Patients With Persistent High Triglycerides (from the ANCHOR Study)
Christie M. Ballantyne et al.
AMERICAN JOURNAL OF CARDIOLOGY (2012)
Differences in arachidonic acid levels and fatty acid desaturase (FADS) gene variants in African Americans and European Americans with diabetes or the metabolic syndrome
Susan Sergeant et al.
BRITISH JOURNAL OF NUTRITION (2012)
n-3 Fatty Acids and Cardiovascular Outcomes in Patients with Dysglycemia
Jackie Bosch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Eicosapentaenoic Acid Ethyl Ester (AMR101) Therapy in Patients With Very High Triglyceride Levels (from the Multi-center, plAcebo-controlled, Randomized, double-blINd, 12-week study with an open-label Extension [MARINE] Trial)
Harold E. Bays et al.
AMERICAN JOURNAL OF CARDIOLOGY (2011)
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
Alessandro Liberati et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
FADS genotypes and desaturase activity estimated by the ratio of arachidonic acid to linoleic acid are associated with inflammation and coronary artery disease
Nicola Martinelli et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2008)
Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial
Luigi Tavazzi et al.
LANCET (2008)
Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised openlabel, blinded endpoint analysis
Mitsuhiro Yokoyama et al.
LANCET (2007)
Share Paper
